Thiophilic ring-opening and rearrangement reactions of epoxyketone natural products

Bioorganic and Medicinal Chemistry Letters

Volumn 8, Issue 4, 1998, Pages 351-356

  Wipf, Peter ^a   Jeger, Patrick ^a   Kim, Yuntae ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; EPOXYKETONE; GLUTATHIONE; KETONE DERIVATIVE; NATURAL PRODUCT; SCAVENGER; UNCLASSIFIED DRUG;

AROMATIZATION; ARTICLE; BIOCHEMISTRY; CONTROLLED STUDY; DRUG SYNTHESIS; NONHUMAN; REACTION ANALYSIS; RESEARCH;

EID: 0032539635     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(98)00026-2     Document Type: Article

References (22)

1. 1. See, for example, Abelson, P. H. Science 1992, 256, 1609.
2. 2. Murphy, J. A.; Griffiths, J. Nat. Prod. Rep. 1993, 551.
3. 3. Rink, S. M.; Solomon, M. S.; Taylor, M. J.; Rajur, S. B.; McLaughlin, L. W.; Hopkins, P. B. J. Am. Chem. Soc. 1993, 115, 2551.
4. 4. Hu, Y.; Melville, C. R.; Gould, S. J.; Floss, H. G. J. Am. Chem. Soc. 1997, 119, 4301.
5. 5. Gould, S. J.; Kirchmeier, M. J.; LaFever, R. E. J. Am. Chem. Soc. 1996, 118, 7663.
6. 6. (a) Wipf, P.; Kim, Y. J. Org. Chem. 1993, 58, 1649.
7. (b) Wipf, P.; Kim, Y.; Fritch, P. C. J. Org. Chem. 1993, 58, 7195.
8. 7. (a) Wipf, P.; Kim, Y. J. Org. Chem. 1994, 59, 3518.
9. (b) Wipf, P.; Kim, Y.; Jahn, H. Synthesis 1995, 1549.
10. 8. (a) Wipf, P.; Xu, W.; Takahashi, H.; Jahn, H.; Coish, P. D. G. Pure Appl. Chem. 1997, 69, 639.
11. (b) Wipf, P.; Coish, P. D. G. Tetrahedron Lett. 1997, 18, 5073.
12. 9. Wipf, P.; Jung, J.-K. Angew. Chem. Int. Ed. Engl. 1997, 36, 764.
13. 10. Fehlhaber, H. W.; Kogler, H.; Mukhopadhyay, T.; Vijayakumar, E. K. S.; Ganguli, B. N., J. Am. Chem. Soc. 1988, 110, 8242.
14. 11. (a) Silverstein, R. B. In The organic chemistry of drug design and drug action; Academic: San Diego, 1992.
15. (b) For a recent example for the use of thiols as models for assessment of the reactivity of antitumor antibiotics, see: Behroozi, S. J.; Kim, W.; Gates, K. S. J. Org. Chem. 1995, 60, 3964.
16. 12. The structure of 2 was confirmed by extensive NOE and decoupling experiments: Kim, Y.; Ph.D. Thesis, University of Pittsburgh, 1995.
17. 13. Wipf, P.; Kim, Y. J. Am. Chem. Soc. 1994, 116, 11678.
18. 14. Baldwin, J. E.; Adlington, R. M.; Mitchell, M. B. Tetrahedron 1995, 51, 5193.
19. 15. Chudek, J. A.; Foster, R.; Reid, F. J. J. Chem. Soc. Perkin Trans. II 1984, 287.
20. 16. Natural product serine-protease inhibitors with α-keto arginine residues such as cyclotheonamide also occur prediminantly as hydrates in aqueous environment. In the enzyme active site, alkylation of the serine-159 side chain hydroxy group occurs presumably via the intermediate ketone: Lee, A. Y.; Hagihara, M.; Karmacharya, R.; Albers, M. W.; Schreiber, S. L.; Clardy, J. J. Am. Chem. Soc. 1993, 115, 12619. Maryanoff, B. E.; Qiu, X. Y.; Padmanabhan, K. P.; Tulinsky, A.; Almond, H. R.; Andradegordon, P.; Greco, M. N.; Kauffman, J. A.; Nicolaou, K. C.; Liu, A. J.; Brungs, P. H.; Fusetani, N. Proc. Nat. Acad. Sci. U.S.A. 1993, 90, 8048.
21. 16. Natural product serine-protease inhibitors with α-keto arginine residues such as cyclotheonamide also occur prediminantly as hydrates in aqueous environment. In the enzyme active site, alkylation of the serine-159 side chain hydroxy group occurs presumably via the intermediate ketone: Lee, A. Y.; Hagihara, M.; Karmacharya, R.; Albers, M. W.; Schreiber, S. L.; Clardy, J. J. Am. Chem. Soc. 1993, 115, 12619. Maryanoff, B. E.; Qiu, X. Y.; Padmanabhan, K. P.; Tulinsky, A.; Almond, H. R.; Andradegordon, P.; Greco, M. N.; Kauffman, J. A.; Nicolaou, K. C.; Liu, A. J.; Brungs, P. H.; Fusetani, N. Proc. Nat. Acad. Sci. U.S.A. 1993, 90, 8048.
22. 17. Hara, M.; Han, M. Proc. Nat. Acad. Sci. U.S.A. 1995, 92, 3333.